Oral administration to patients of a bacterial cocktail of these species together with the anti-PD-L1 antibody specifically increases the T cell response and blocks the growth of melanoma, whereas if the treatment is combined with antibiotics, the survival rate is reduced [15]. The gene discussed is CD274; the disease is melanoma.